Division of Colorectal Surgery, NewYork-Presbyterian Hospital/Columbia University Medical Center, Herbert Irving Pavilion, 161 Fort Washington Avenue, Floor 8, New York, NY, 10032, USA.
Center for Innovation and Outcomes Research, Department of Surgery, NewYork-Presbyterian Hospital/Columbia University Medical Center, New York, NY, USA.
J Gastrointest Surg. 2018 Jun;22(6):1043-1051. doi: 10.1007/s11605-018-3699-8. Epub 2018 Feb 5.
The study aims to evaluate the clinical and financial outcomes of the use of robotic when compared to laparoscopic colorectal surgery and any changes in these over time.
From the Premier Perspective database, patients who underwent elective laparoscopic and robotic colorectal resections from 2012 to 2014 were included. Laparoscopic colorectal resections were propensity score matched to robotic cases for patient, disease, procedure, surgeon specialty, and hospital type and volume. The two groups were compared for conversion, hospital stay, 30-day post-discharge readmission, mortality, and complications. Direct, cumulative, and total (including 30-day post-discharge) costs were evaluated. Clinical and financial outcomes were also separately assessed for each of the included years.
Of 36,701 patients, 32,783 (89.3%) had laparoscopic colorectal resection and 3918 (10.7%) had robotic colorectal resection; 4438 procedures (2219 in each group) were propensity score matched. For the entire period, conversion to open approach (4.7 vs. 3.7%, p = 0.1) and hospital stay (mean days [SD] 6 [5.3] vs. 5 [4.6], p = 0.2) were comparable between robotic and laparoscopic procedures. Surgical and medical complications were also the same for the two groups. However, the robotic approach was associated with lower readmission (6.3 vs. 4.8%, p = 0.04). Wound or abdominal infection (4.7 vs. 2.3%, p = 0.01) and respiratory complications (7.4 vs. 4.7%, p = 0.02) were significantly lower for the robotic group in the final year of inclusion, 2014. Direct, cumulative, and total (including 30-day post-discharge) costs were significantly higher for robotic surgery. The difference in costs between the two approaches reduced over time (direct cost difference: 2012, $2698 vs. 2013, $2235 vs. 2014, $1402).
Robotic colorectal surgery can be performed with comparable clinical outcomes to laparoscopy. With greater use of the technology, some further recovery benefits may be evident. The robotic approach is more expensive but cost differences have been diminishing over time.
本研究旨在评估与腹腔镜结直肠手术相比,使用机器人手术的临床和财务结果,并随时间观察这些结果的变化。
从 Premier 透视数据库中,选取 2012 年至 2014 年间接受择期腹腔镜和机器人结直肠切除术的患者。对腹腔镜结直肠切除术患者进行倾向评分匹配,以与机器人病例匹配患者、疾病、手术、外科医生专业、医院类型和规模。比较两组患者的中转手术、住院时间、30 天出院后再入院、死亡率和并发症。评估直接、累计和(包括 30 天出院后)总费用。还分别评估了纳入的每一年的临床和财务结果。
在 36701 名患者中,32783 名(89.3%)接受了腹腔镜结直肠切除术,3918 名(10.7%)接受了机器人结直肠切除术;4438 例(2219 例在每组)进行了倾向评分匹配。在整个研究期间,开放手术中转率(4.7%比 3.7%,p=0.1)和住院时间(平均天数[标准差]6[5.3]比 5[4.6],p=0.2)在机器人和腹腔镜手术之间无差异。两组患者的手术和医疗并发症也相同。然而,机器人手术组的再入院率较低(6.3%比 4.8%,p=0.04)。在纳入的最后一年(2014 年),机器人组的手术部位或腹部感染(4.7%比 2.3%,p=0.01)和呼吸系统并发症(7.4%比 4.7%,p=0.02)显著降低。机器人手术的直接、累计和(包括 30 天出院后)总费用显著更高。两种方法之间的成本差异随时间减少(直接成本差异:2012 年,$2698 比 2013 年,$2235 比 2014 年,$1402)。
机器人结直肠手术可获得与腹腔镜手术相当的临床结果。随着技术的广泛应用,可能会出现一些进一步的康复益处。机器人手术方法更昂贵,但成本差异随时间缩小。